GLP-1 Weight Loss Drugs: Many Patients Restart or Switch Therapies After Stopping A recent study indicates that many individuals who discontinue glucagon-like peptide-1 receptor agonist (GLP-1 RA) medications for weight …
Receptor
-
-
Gut Microbiome May Predict Response to GLP-1 Weight Loss Medications New research highlights the growing understanding of how the gut microbiome influences the effectiveness of glucagon-like peptide-1 receptor agonists (GLP-1 …
-
New Combination Therapy Shows Promise in Pancreatic Cancer Treatment Pancreatic ductal adenocarcinoma (PDAC), one of the most aggressive forms of cancer, has proven challenging to treat, particularly due to the …
-
Single Receptor PAR1 Controls Opposing Responses in Blood Vessels Researchers at the University of California San Diego have uncovered a critical mechanism in blood vessel function: a single protein, called …
-
New Platform Enhances CAR T-Cell Therapy for Relapsed Leukemia Chimeric antigen receptor (CAR) T-cell therapy has revolutionized the treatment of leukemia, but relapse remains a significant challenge. Now, a novel …
-
Prostate Cancer Treatment: Blood Thinner Concerns Allayed in New Study New research offers reassurance to patients with advanced prostate cancer undergoing treatment with androgen-receptor pathway inhibitors. A study published in …
-
GLP-1 Medications May Reduce Risk of Addiction, Study Finds A large-scale study of US veterans suggests that medications commonly prescribed for type 2 diabetes may also be associated with a …
-
Lettuce-Delivered GLP-1s: A Potential Game Changer for Diabetes and Obesity Treatment Glucagon-like peptide-1 (GLP-1) receptor agonists have rapidly become a focal point in the treatment of both type 2 diabetes …
-
GLP-1 Receptor Agonists: A New Era in Metabolic and Cardiovascular Health A sweeping review published in The Lancet reveals how modern incretin-based drugs are reshaping treatment for obesity and diabetes, …
-
Blocking Growth Hormone Receptor Shows Promise in Combating Treatment-Resistant Lung Cancer Lung cancer remains the leading cause of cancer-related deaths globally, but a new study from Ohio University suggests a …